Electroretinograms after administration of triamterene
Tota, G.; Cavallacci, G.
Annali di Ottalmologia E Clinica Oculistica 97(4): 143-153
1971
ISSN/ISBN: 0003-4665 PMID: 5149606 Document Number: 39414
Document emailed within 1 workday
Related Documents
IIjima, H.; Yamaguchi, S. 1990: Adaptational changes in cone electroretinograms in man Nippon Ganka Gakkai Zasshi 94(11): 987-992Shimada, Y. 2002: The concept of induced components in multifocal electroretinograms Nippon Ganka Gakkai Zasshi 106(2): 69-76
Miyamura, N.; Uji, Y. 1992: Effects of carteolol on electroretinograms in isolated perfused cat eye Nippon Ganka Gakkai Zasshi 96(7): 878-883
Yu, M.; Zhang, X.; Zhong, X.; Yu, Q.; Jiang, F.; Ma, J.; Wu, D. 2002: Multifocal electroretinograms in the early stages of diabetic retinopathy Chinese Medical Journal 115(4): 563-566
Cruz, R.D.; Adachi-Usami, E.; Kakisu, Y. 1990: Flash electroretinograms and pattern visually evoked cortical potentials in Behçet's disease Japanese Journal of Ophthalmology 34(2): 142-148
Conte, J.; Suc, J.M. 1974: Anti-hypertensive action of triamterene La Nouvelle Presse Medicale 3(45): 2741-2742
Penisson-Besnier, I.; Cesbron, J.G.; L'Heveder, G.; Laine-Cessac, P.; Dubas, F. 1993: Efficacy of triamterene in hydrocephalus in adults Presse Medicale 22(5): 224-225
Krause, K.; Gerding, H.; Hanneken, L.; Cremer-Bartels, G.; Sellerberg, D.; Wortmeier, M. 1993: The effect of triamterene on the ERG of Long-Evans rats Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 90(2): 136-139
Goldman, M.; Zegers de Beyl, D.; Delwiche, F.; Bellens, R. 1980: Triamterene-induced pancytopenia in idiopathic haemochromatosis Acta Clinica Belgica 35(4): 265-266
Fuhr, U.; Kober, S.; Zaigler, M.; Mutschler, E.; Spahn-Langguth, H. 2005: Rate-limiting biotransformation of triamterene is mediated by CYP1A2 International Journal of Clinical Pharmacology and Therapeutics 43(7): 327-334
Felder, K.; Geissler, H.E.; Hiemstra, S.; Mutschler, E.; Schäfer, M.; Ziegler, E. 1979: Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamterene Arzneimittel-Forschung 29(11): 1746-1752
Felix, W.; Manz, M. 1975: Effect of triamterene and bemetizide on transcapillary water metabolism Die Medizinische Welt 26(21): 1043-1050
Fairley, K.F.; Woo, K.T.; Birch, D.F.; Leaker, B.R.; Ratnaike, S. 1986: Triamterene-induced crystalluria and cylinduria: clinical and experimental studies Clinical Nephrology 26(4): 169-173
Dao, M.T.; Villeneuve, J.P. 1988: Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 6-9
Schalhorn, A.; Wilmanns, W. 1979: Inhibition of human leukocytes dihydrofolate reductase by triamterene and its metabolites Arzneimittel-Forschung 29(9): 1409-1411
Pillegand, B.; Tournier, C.; Rumeau, J.M.; Claude, R. 1977: Acute pancytopenia in a cirrhotic patient treated by triamterene. a new case La Nouvelle Presse Medicale 6(33): 3004-3005
Baudin, S.; Rodrigue, H. 1980: Drug induced nephrolithiasis: observation of an oxalate and hydroxylated triamterene stone Nephrologie 1(4): 183-185
Völger, K.D. 1991: Animal experimental and human pharmacologic studies with phase-Ii metabolites of triamterene Arzneimittel-Forschung 41(5): 499-506
Pörsti, P.; Jalonen, K.; Ryysy, L.; Toivonen, T.; Viherkoski, M. 1981: Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene Annals of Clinical Research 13(1): 6-10
Schwinger, R.H.; Antoni, D.H. 1992: Triamterene may preserve lymphocyte magnesium and potassium in patients with congestive heart failure Magnesium Research 5(1): 29-32